Drugs · acquisition-cost intelligence
GAVILYTE-N
polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate· ingredient polyethylene glycol 3350Electrolyte solutions· POLYETHYLENE GLYCOL 3350 420 g/438.4g; POTASSIUM CHLORIDE 1.48 g/438.4g; POLYETHYLENE GLYCOL 3350 420 g/4L; POTASSIUM CHLORIDE 1.48 g/4L
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.00569
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other polyethylene glycol 3350 products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| GaviLyte - C TM | $0.00373 | −$0.00200 |
| GAVILYTE G TM | $0.00465 | −$0.00100 |
| basic care clearlax | $0.02458 | +$0.01890 |
| SUFLAVE | $61.64 | +$61.64 |
Medicare Part D coverage · CY2026
On 327 plan formularies · typical tier 2
Prior auth 0% · Step therapy 0% · Quantity limit 0% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.